Sharechat Logo

Synlait to double lactoferrin output with $18M investment after securing customer

Thursday 5th April 2018

Text too small?

Synlait Milk said it will spend about $18 million to double production of lactoferrin at its Dunsandel plant after securing a multi-year agreement to supply the high-value milk protein.

 

The dairy company didn't identify the customer but said a demand and supply imbalance "is driving global strengthening of lactoferrin prices and demand is notably driven from increasing use of lactoferrin in infant formula, particularly in China." It expects to complete the expansion by October.

 

"As a specialty ingredient, lactoferrin commands a much higher price per metric tonne than many other dairy-based ingredients," said Elizabeth Reid, a group category manager at Synlait, in a statement.

 

Last year Synlait gained a GRAS (Generally Recognised As Safe) notice from the US Food and Drug Administration to export lactoferrin to the US for use in infant formula and toddler formula, saying at the time it was only the second company worldwide to get that status.

 

The company is coy about the financial details of its lactoferrin business. Its 2017 annual report says it sold 11 metric tonnes of the iron-binding protein last year, up from 10 tonnes in 2016. According to Synlait, the specialty ingredient is recognised for its anti-bacterial and anti-inflammatory properties.

 

Last month, Synlait posted a record first-half profit of $40.7 million, which it attributed to production and sales of high-margin products and its partnership with A2 Milk.

 

Synlait shares rose 2 percent to $9.13 and have soared 169 percent in the past 12 months.

 

(BusinessDesk)

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

MARKET CLOSE: NZ shares rise as optimism over US-China trade deal lingers; Fletcher gains
NZD under pressure against Aussie as investors cheered by easing of trade jitters
PFI properties’ valuation rises 5.5% to $1.32 billion
Broader definition of workplace harm in new govt health & safety strategy
MBIE officials grilled on terms of Westland Milk loan
Trade Me suitor Hellman & Friedman drops out
Hydrogen not a short-term option for Huntly - Genesis
Kiwibank says customers have a dwindling need of physical branches
Buying off the plans driving down KiwiBuild cost to govt: HYEFU
Fiscal policy to slow growth over next five years, despite surpluses

IRG See IRG research reports